中药复方联合四联疗法治疗难治性幽门螺旋杆菌感染一例
A Case of Refractory Helicobacter pylori Infection Treated by Chinese Herbal Compound Combined with Quadruple Therapy

幽门螺旋杆菌(HP)感染是一种常见的全球感染性疾病，其传染性强，全球感染力高达50%，目前我国人群感染率40%~60%。由于抗生素的滥用，幽门螺旋杆菌的根除率越来越低，有部分患者多次使用标准四联疗法，仍未根除成功。周雪雷教授以四联疗法为基础，联合中药复方，治疗难治性幽门螺旋杆菌感染患者一例，治疗效果满意，值得参考。
Helicobacter pylori (HP) infection is a common global infectious disease with strong infectivity and a global infectivity of up to 50%. At present, the infection rate of people in China is 40%~60%. At present, due to the abuse of antibiotics, the eradication rate of Helicobacter pylori is becoming lower and lower. Professor Zhou Xuelei treated a case of patients with refractory helicobacter pylori infection on the basis of quadruple therapy combined with traditional Chinese medicine compounds, and the therapeutic effect was satisfactory and worthy of reference.